ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTER01

Replication studies for Kaposi Sarcoma mice

Completed
Institution
UNIV OF NORTH CAROLINA CHAPEL HILL, NC
Principal investigator
Dirk P Dittmer
Funding
$78K
Duration
2024–2026
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY/ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-RM- 24-013. Angiogenesis is central to cancer development; together with Angiosarcoma and Hemangioma, Kaposi Sarcoma (KS) is the most angiogenic cancer in humans. KS is the most common cancer in people living with HIV worldwide. In the USA today, KS is concentrated in underrepresented minorities (URM) of black race or Hispanic ethnicity as well as in underserved and marginalized populations. The current frontline regimen for KS was developed in the 1980s. Despite its discovery over 25 years ago, no proper, immune-competent animal model existed for KS or aggressive angiosarcoma until last year, when we published a novel genetically engineered mouse model (GEMM) funded by RO1 CA250080. This novel GEMM fills a gap that has hampered novel therapy and vaccine developments for these cancers. The last experiment in our manuscript describes the first drug evaluation in this new cancer model. We propose repeating this experiment with an independent CRO to establish a repeatable, robust, and rigorous basis for the field. This will yield a best practices manual for drug testing in this model.

LOADING MOONBASE SCORE

R01NATIONAL CANCER INSTITUTEsarcomadrug testingkaposikaposi sarcomagemmrepeatingexperimentcancer model

Questions for UNIV OF NORTH CAROLINA CHAPEL HILL

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.